© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
BioLife Solutions, Inc. (BLFS) stock declined over -0.60%, trading at $23.09 on NASDAQ, down from the previous close of $23.23. The stock opened at $22.88, fluctuating between $22.80 and $23.70 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 20, 2026 | 22.97 | 23.70 | 22.80 | 23.09 | 236.39K |
| Feb 19, 2026 | 22.59 | 23.25 | 22.19 | 23.23 | 242.95K |
| Feb 18, 2026 | 22.61 | 23.09 | 22.14 | 22.84 | 359.34K |
| Feb 17, 2026 | 22.10 | 22.66 | 21.71 | 22.36 | 268.15K |
| Feb 13, 2026 | 21.77 | 22.45 | 21.75 | 22.23 | 288.5K |
| Feb 12, 2026 | 22.36 | 22.36 | 21.45 | 21.58 | 240.09K |
| Feb 11, 2026 | 22.74 | 22.99 | 21.75 | 22.25 | 207K |
| Feb 10, 2026 | 22.78 | 22.97 | 22.40 | 22.65 | 244.47K |
| Feb 09, 2026 | 22.24 | 22.92 | 21.77 | 22.63 | 424.53K |
| Feb 06, 2026 | 22.00 | 22.66 | 21.35 | 22.43 | 453.44K |
| Feb 05, 2026 | 22.50 | 23.08 | 21.85 | 22.02 | 427.88K |
| Feb 04, 2026 | 23.07 | 23.42 | 21.96 | 22.67 | 686.63K |
| Feb 03, 2026 | 22.35 | 23.51 | 22.18 | 22.84 | 957.59K |
| Feb 02, 2026 | 21.91 | 22.72 | 21.76 | 22.33 | 377.27K |
| Jan 30, 2026 | 22.34 | 22.79 | 21.78 | 21.80 | 364.38K |
| Jan 29, 2026 | 22.90 | 23.03 | 22.36 | 22.58 | 387.45K |
| Jan 28, 2026 | 25.09 | 25.22 | 22.88 | 22.94 | 383.58K |
| Jan 27, 2026 | 24.86 | 25.21 | 24.59 | 24.98 | 180.01K |
| Jan 26, 2026 | 24.81 | 25.01 | 24.46 | 24.94 | 214.85K |
| Jan 23, 2026 | 25.81 | 25.94 | 24.63 | 24.87 | 269.32K |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
| Employees | 159 |
| Beta | 1.92 |
| Sales or Revenue | $143.27M |
| 5Y Sales Change% | 1.698% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |